Why the study?
Does the use of beta blockers, calcium-channel blockers, or ACEI/ARBs improve survival after in-clinic cardiac arrest in hemodialysis patients?
Population
729 hemodialysis patients who experienced in-center cardiac arrest in the Gambro Healthcare System in the…
Comparison
Use of beta blockers, calcium-channel blockers… vs Patients not taking these medications at the…
Design
Cohort
Follow-up
6 months
Authors
Loading...
May support these agents post-arrest in hemodialysis; hypothesis-generating and should not yet change practice.
Does the use of beta blockers, calcium-channel blockers, or ACEI/ARBs improve survival after in-clinic cardiac arrest in hemodialysis patients?
In hemodialysis patients experiencing in-clinic cardiac arrest, baseline use of beta blockers, calcium-channel blockers, and ACEI/ARBs is associated with improved survival at 24 hours and 6 months.
Pun et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: